CD44 and breast carcinoma: Interestingly, α6 integrin has also been shown to be required for the growth and survival of breast cancer cells [23], and an increased expression of CD44 has been observed in cells displaying an apoptotic resistance, in line with a decreased p53 expression [22] or an increased p63 expression [24].